Management and Outcomes of a First Recurrence of Clostridium difficile-Associated Disease in Quebec, Canada
Author(s) -
JeanLouis Pépin,
Sonia Routhier,
Sandra Gag,
I. Brazeau
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/501126
Subject(s) - medicine , metronidazole , toxic megacolon , clostridium difficile , vancomycin , colectomy , surgery , perforation , proportional hazards model , complication , enterocolitis , disease , antibiotics , ulcerative colitis , genetics , materials science , bacteria , punching , biology , staphylococcus aureus , metallurgy , microbiology and biotechnology
During an epidemic of Clostridium difficile-associated disease (CDAD) caused by a strain that is a hyper-producer of toxins A and B, the frequency of a first recurrence after metronidazole treatment of the initial episode doubled in 2003-2004, compared with 1991-2002.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom